CAPITAL IMPACT ADVISORS, LLC Blueprint Medicines Corporation Transaction History

CAPITAL IMPACT ADVISORS, LLC portfolio value:

$312,000
portfolio value

CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:

+30.45%
quarter

Blueprint Medicines Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +21.98% 1.32K shares 9K $65.89 7.32K
Q2 2022 share Decrease -28.61% -2.40K shares -234K $50.51 6.00K
Q1 2022 share Increase +9.70% 744 shares -284K $63.88 8.41K
Q4 2021 share Increase 0.00% 7.66K shares 821K $109.45 7.66K